ribociclib
novartis
['natalee', 'breast', 'novartis', '$nvs']
aes from natalee adjuvant breast trial. novartis says neutropenia a third lower than higher mestastatic disease dose. also notes low qtc prolongation. could trial exclusions change that in real world, however? that was a question raised at #asco23 press event this week $nvs 
Pharma and biotech reporter, found a home at Evaluate Vantage.